Cipla Ltd.

Cipla has completed the acquisition of 100% of the issued shares of Medpro. The listing of the shares of Medpro on the JSE has been terminated from the commencement of business on July 16, 2013.

Earlier, the company had received an approval from the Takeover Regulation Panel for its proposal to takeover Medpro in South Africa. The company had also received approval from shareholders of Cipla Medpro to Cipla $488 million offer to acquire 100 per cent stake in it.

The company focuses on development of new formulations and has a wide range of pharmaceutical products. It offers prescription drugs, bulk drugs, animal products and pesticides. It also offers a wide range of food and beverages, baked foods, oral hygiene products, detergents, room fresheners and personal care products.